Person
Dario Amodei
4 documents in the archive.
Appearances newest first
2-1 D.C. Circuit keeps one DoD supply-chain risk designation on Anthropic; conflicts with N.D. Cal. vacatur of a parallel label.
Anthropic primary: Claude agents spotted array-associated reverse transcriptases in jumbo phage DNA; lab verified; function still open.
NYT via Bloomberg: Anthropic annualized revenue expected above $100B this year; separate WSJ/Reuters lanes point to a possible November IPO window.
Anthropic primary: Faculty/Accenture as first embedded evaluator under Amodei’s pacing plan; each side expects ≥$1B over 5y; Anthropic funds Accenture.